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Abstract
Background: HIV is still a global public health problem. More than 75 % of HIV-infected people are in Africa, and
most of them are unaware of their HIV status, which is a barrier to accessing antiretroviral treatment. Our review
aims, firstly, to determine whether HIV self-testing is an effective method to increase the uptake of testing, the yield
of new HIV-positive diagnoses, and the linkage to antiretroviral treatment. Secondly, we aim to review the factors
that facilitate or impede the uptake of HIV self-testing.
Methods/design: Participants will be adults living in Africa. For the first aim, the intervention will be HIV self-testing
either alone or in addition to HIV testing standard of care. The comparison will be HIV testing standard of care. The
primary outcomes will be (i) uptake of HIV testing and (ii) yield of new HIV-positive diagnoses. The secondary
outcomes will be (a) linkage to antiretroviral (ARV) treatment and (b) incidence of social harms. For the second aim, we
will review barriers and facilitators to the uptake of self-testing. We will search PubMed, Cochrane Central Register of
Controlled Trials, Scopus, Web of Science, WHOLIS, Africa Wide, and CINAHL for eligible studies from 1998, with no
language limits. We will check reference lists of included studies for other eligible reports. Eligible studies will include
experimental and observational studies. Two authors will independently screen the search output, select studies, and
extract data, resolving discrepancies by consensus and discussion. Two authors will use Cochrane risk of bias tools for
experimental studies, the Newcastle-Ottawa Quality Assessment Scale for observational studies, and the Critical
Appraisal Skills Programme (CASP) quality assessment tool for qualitative studies.
Discussion: Innovative and cost-effective community-based HIV testing strategies, such as self-testing, will contribute
to universal coverage of HIV testing in Africa. The findings from this systematic review will guide development of self-
testing policy in African countries.
Systematic review registration: PROSPERO CRD42015023935
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Background
Globally, an estimated 35.0 million people are living with
HIV, with more than 2.1 million (1.9 million–2.4 million)
new HIV infections and 1.5 million deaths in 2013 [1].
Africa remains the most affected region, contributing
more than two thirds of the global burden of HIV [2]. The
UNAIDs/WHO has set a “90-90-90” global target to be
reached by 2020. The global target stipulates that 90 % of
adults will know their HIV status, 90 % of HIV positive
will receive sustained antiretroviral (ARV) treatment, and
90 % of those who are on ARV treatment will achieve viral
load suppression by 2020 [3].
Despite substantial efforts to increase HIV testing, par-
ticularly in populations with generalized HIV epidemics,
testing coverage in Africa is low. A recent review of
Demographic and Health Surveys reported that across 29
Sub-Saharan Africa (SSA) countries, only 15 % of adults
received HIV test result in the past 12 months [4]. The
observed low coverage is a critical barrier to scaling up
HIV prevention, care, and treatment interventions. In
addition, evidence suggests that most HIV-positive people
in Africa seek late entry to ARV treatment and the delay
has adverse impact on treatment outcomes, including high
mortality, avoidable morbidity, and transmission of the
virus [5, 6].
Evidence shows that HIV self-testing (HIVST) has the
potential to empower non-testers to know their HIV
status by overcoming facility-based barriers to HIV testing
[7]. However, HIV policy makers have reservations about
the introduction of self-testing and raise concerns regard-
ing HIVST. The concerns vary from lack of policies and
regulatory systems, quality of HIVST kits, ethical and
human rights issues, and knowledge gaps pertaining to
HIVST [8–10].
Apart from general concerns described above, there
are several barriers associated with uptake of HIVST.
Perceived accuracy of self-testing kits is a major barrier
to uptake of HIVST, with evidence of uncertainty on
perceptions of the accuracy of self-test kits [11]. The
invasive nature of a finger prick for obtaining a blood
sample is another barrier, particularly for blood-based
self-testing because some people fear needle pricks [12].
The cost of buying self-test kits is another barrier. Most
consumers have to pay for the self-test kits, ranging
from US$ 4.8 to US$ 40, which may not be affordable to
most people in low- and middle-income countries
(LMICs), including SSA [8, 13]. Finally, illiteracy is an-
other barrier associated with uptake of HIVST. Evidence
shows that illiterate participants are less likely to under-
take self-testing compared to their literate counterparts,
particularly in an unsupervised self-testing strategy [13].
The current evidence on barriers to uptake of HIVST is
from studies conducted in high-income settings and only
four studies from Africa.
Three systematic reviews provided evidence on self-
testing, globally. The reviews focused on HIVST strat-
egies in low- and high-risk populations and acceptability
of HIVST in high- and low-income countries. Pai et al.’s
review reported a high acceptability, ranging from 74 to
96 % in high- and low-income countries. In addition, the
review observed a higher preference for self-testing com-
pared to facility-based testing and oral-based rather than
blood-based self-testing [14]. Krause et al.’s review found
that 50 to 60 % of participants were first-time testers. In
addition, the review provided evidence of high perform-
ance accuracy rates of 99 % among laypersons compared
to health-care providers. The review concluded that
HIVST has a potential to reach first-time testers with
high performance accuracy rates among laypersons
[15]. Suthar et al.’s review, which compared different
community-based HIV testing approaches, reported
participant’s high uptake of self-testing of 86.9 %
compared with 62 % of a school-based HIV testing.
The review concluded that community-based HIV
approaches, including self-testing, have high rate of
testing uptake [16]. The current reviews focused
mainly on studies from high-income settings, with
only four studies (Malawi n = 3; Kenya = 1), were from
African countries. The four studies lack evidence on
yield of new HIV-positive diagnoses, post-test linkage
to ARV treatment, and incidence of social harms
post-testing [17]. However, since the last reviews in
2014, five new African studies on self-testing have
been published.
Of importance is the fact that apart from WHO rec-
ommendation for introduction of HIVST as a strategy to
increase universal coverage of HIV testing and counsel-
ing (HTC) [18], most African countries lag behind in
terms of integration of HIVST in their national HTC
guidelines [9]. In addition, there is a concern that with
HIV self-testing, linkage to treatment (i.e., HIV-positive
clients receiving sustainable ARV treatment) might be
compromised [19]. A key challenge with HIVST imple-
mentation is ensuring people who test positive are not
alienated from health services where ARV treatment is
provided, because of the privacy and lack of post-test
counseling associated with self-testing [8]. In order to
answer this pertinent question, we propose to conduct
this review. The aim of this study is to review the exist-
ing evidence on the effects of HIVST on the uptake of
testing, the yield of new HIV-positive diagnoses, linkage
to ARV treatment, incidence of social harms, and the
factors that facilitate and impede the uptake of HIVST
among adults in Africa.
Aims
The first aim is to evaluate the effectiveness of HIV self-
testing interventions on (i) the uptake of HIV testing, (ii)
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the yield of new HIV-positive diagnoses, linkage to ARV
treatment, and (iii) incidence of social harms among
adults in Africa.
The second aim is to review the barriers and facilitators
to the uptake of self-testing among adults in Africa.
Methods
This review has been registered in the PROSPERO
International Prospective Register of systematic re-
views (http://www.crd.york.ac.uk/PROSPERO), regis-
tration number CRD42015023935 [20].
Eligibility criteria
Study designs
For the review of the intervention effects, experimental
studies including randomized controlled trials (RCTs),
controlled before/after studies, and interrupted time series
studies will be considered for inclusion in this review. Ex-
perimental studies will assess the effects on uptake, yield,
incidence of social harms, and linkage to ARV treatment.
In addition, given that this is an emerging area of research,
we will conduct secondary supplementary analysis of ob-
servational studies that assessed the outcomes of interest
in this review. These studies will be included in a separate
section of the review results.
For the review of barriers and facilitators, we will include
predominantly observational studies which include data on
the factors which facilitate or impede the uptake of self-
testing. We will employ a broad definition of observational
studies and include all studies that utilize qualitative
methods for data collection (i.e., focus groups, in-depth in-
terviews, observation, and review of documents) and ana-
lysis by the contextual attributes, such as factors associated
with gender, culture, ethnicity, and geographical settings.
Participants
The study participants are adults (males and females)
from African countries.
Intervention
The intervention of this study is HIV self-testing. HIV
self-testing refers to a process whereby an individual,
who is willing to know his/her HIV status, collects his/
her own specimen, performs the HIV test, and interprets
the results in private at home or in other settings.
For the review of the intervention effects, the inter-
vention condition is HIV self-testing, either alone or in
addition to the standard of care in HIV testing. The com-
parison condition is HIV testing standard of care. This
might involve (1) provider-administered testing, (2) door-
to-door testing, (3) mobile testing, (4) index testing, (5)
work place testing, and (6) client-initiated testing or some
combination of these approaches.
Outcomes
For the review of the intervention effects, the primary out-
comes are uptake of testing and yield of new HIV-positive
diagnoses among adults in African countries. The primary
outcomes are defined as:
 Uptake: the proportion of individuals who underwent
HIV testing and received their test results over those
who were offered HIV testing [21].
 Yield of new HIV-positive diagnoses: the propor-
tion of individuals who were newly diagnosed
with HIV positive over those who were offered
HIV testing [22, 23].
The secondary outcomes are defined as:
 Linkage into ARV treatment: proportion of newly
diagnosed HIV-positive adults who are enrolled in
ARV treatment at any point in time post-testing
over all newly diagnosed HIV-positive adult
participants [24].
Social harm: proportion of participants who report any
episode of harm during or after HIV testing (e.g.,
intimate partner violence, coercive testing by a partner,
or suicide) [25].
Editorials, reviews, perspectives, and studies not evalu-
ating self-testing strategies (e.g., home-based testing) will
be excluded. Studies, which will not clearly define the
type of HIV testing strategies or include subjects below
18 years old will also be excluded. We will not consider
studies that included health-care providers. Any dis-
agreements in study inclusion/exclusion will be resolved
at a meeting between reviewers. For the qualitative stud-
ies, we will collect additional information concerning (a)
barriers to the uptake of self-testing, (b) facilitators to
the uptake of self-testing, and (c) experiences of adults
who had participated in self-testing in any African
countries.
Setting




We will conduct two separate search strategies for aims
one and two. For the review of the intervention effects, a
comprehensive search strategy will be developed to iden-
tify both published and unpublished articles with no lan-
guage restrictions from 1998 to 31st December 2015.
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This search restriction is used because since 1998, we
have seen the emergence of advance developments of
rapid HIV diagnostic tests (RDTs) including self-testing
[26]. The review will search for related studies in
PubMed, the Cochrane Central Register of Controlled
Trails (CENTRAL), the Cochrane Database of System-
atic Reviews (CDSR), Databases of Abstracts of Reviews
of Effectiveness (DARE), Social Sciences Citation Index,
Web of Science, and African Index Medicus. In
addition, we will search websites and databases for
gray materials such as World Health Organization Li-
brary Information System (WHOLIS), WHO Global Index
Medicus, the Joint United Nations Programme on HIV/
AIDS (UNAIDS resource library), Alliance of Health Pol-
icy and Systems Research, and The World Bank. The
search strategies for electronic databases will incorporate
Medical Subject Headings (MeSH), free-text terms, and
comprehensive African search filter that will be adapted
to suit each individual database using applicable con-
trolled vocabulary [27, 28]. We will also check reference
lists of included studies for other eligible reports.
For the review of barriers and facilitators, we will search
for related studies in CINAHL and MEDLINE electronic
databases using guidelines developed by the Cochrane
Qualitative Research Methods Groups for searching for
qualitative evidence [29]. Previous qualitative work has
demonstrated that CINAHL and MEDLINE are the most
important resource for qualitative evidence [30]. In
addition to the abovementioned databases, we will search
other resources for related articles, contact experts in the
field, gray literature, and scan reference lists of relevant
studies.
Search strategy
For the review of the intervention effects, we will use
various MeSH and search terms such as “adult,” “HIV,”
“Human Immunodeficiency Virus,” “AIDS,” “Acquired
Immunodeficiency Syndrome,” “self testing,” “HIV self-
testing,” “HIVST,” “testing,” “counseling,” “provider-ad-
ministered testing,” “uptake,” “yield,” “prevalence,” “HIV
positivity,” “linkage,” “care,” “treatment,” Africa,” and
“Africa South of the Sahara”. Searches will combine with
the names of each country in Eastern, Northern, and
Southern Africa by using the Boolean operators “OR”
or “AND” (Additional file 1).
For the review of barriers and facilitators, we will use
search terms for Boolean search strategy such as “adult,”
“HIV,” “Human Immunodeficiency Virus,” “AIDS,”
“Acquired Immunodeficiency Syndrome,” “self testing,”
“HIV self-testing,” “HIVST,” “barriers,” “facilitators,”
“HIV self-testing experiences,” Africa,” and “Africa South
of the Sahara”. We will use various combinations of
these terms with the search engines.
Study records
Data management
All search results will be merged into reference manage-
ment software EndNote, and duplicate records of the
same report will be removed.
Selection process
Full copies of articles identified by the search, and which
meet the inclusion criteria, based on the title and
abstract will be obtained for data synthesis. Firstly, two
reviewers will independently apply the inclusion criteria
to the results of the searches, based on the titles and
abstracts alone.
Data collection process
Two reviewers will extract data using a pre-designed
data extraction forms and summarize the most import-
ant information from each study independently. A third
reviewer will be consulted to resolve any differences of
opinion between the two reviewers if they may arise. We
will conduct a pilot trial of both data extraction forms to
check its adequacy and make changes if necessary.
Data items
Where possible, extracted data will include study details,
setting of the study (e.g., city/country/or rural/urban or
facility-based/community-based), year of publication—1998
to date, and type of HIV self-testing (e.g., supervised or
unsupervised) (Additional files 2 and 3).
Risk of bias in included studies
Two reviewers will code each included study using
Cochrane risk of bias tools for RCT studies [31] and the
Newcastle-Ottawa Quality Assessment Scale for obser-
vational studies [32]. This will be supplemented with the
Effective Practice and Organisation of Care (EPOC)
“Risk of bias” guidance to assess the risk of bias of non-
randomized studies [33]. Studies will be assessed on se-
quence generation; allocation concealment; blinding of par-
ticipants, personnel, and outcome assessors; incomplete
outcome data; selective outcome reporting; and other
sources of bias and rated as low risk/or adequate, high risk/
or inadequate, and unclear [34] (Additional file 2).
We will use the Critical Appraisal Skills Programme
(CASP) quality assessment tool to assess the methodo-
logical quality of the qualitative studies [35, 36]. This
tool includes the following 14 questions: (1) Is this study
qualitative research? (2) Are the research questions
clearly stated? (3) Have ethical issues been taken into
consideration? (4) Is the qualitative approach clearly jus-
tified? (5) Is the approach appropriate for the research
question? (6) Is the study context clearly described? (7)
Is the role of the researcher clearly described? (8) Is the
sampling method clearly described? (9) Is the sampling
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strategy appropriate for the research question? (10) Is
the method for data collection clearly described? (11) Is
the data collection method appropriate for the research
question? (12) Is the method of analysis clearly de-
scribed? (13) Is the chosen analytical approach suitable
for addressing the research question? and (14) Are the
claims made supported by sufficient evidence? [36]. We
will conduct a pilot trial on four included studies to
assess the feasibility of the use of the tool and ensure in-
tegrity of the assessment. The quality assessment for risk
of bias will be cross-checked by a third reviewer for
discrepancies.
Quantitative data analysis and synthesis
We will express the results of each study as risk ratios
with corresponding 95 % confidence intervals. We will
combine the estimates according to the study design;
that is, we will pool estimates for each stratum (by
design of the study). We will not combine data across
different types of design. Random effects meta-analysis
will be preferred due to anticipated heterogeneity in
study results. The study will use the log relative risks for
intervention studies using the generic inverse variance
method in Cochrane Review Manager [37]. If we
encounter variation in reported outcome measures
between studies, median effect sizes will be presented
(with a range).
Dealing with missing data
The study will make efforts to contact corresponding au-
thors to request for clarification of all relevant informa-
tion in case of missing data. In case the corresponding
author fails to respondent within a week of requesting
for information, other author(s) will be contacted (copy-
ing the first author). A full description of missing data
and drop-outs for each included study will be elaborated
in the risk of bias table and discuss the extent to which
the missing data could alter the results. The study will
conduct sensitivity analyses to assess the effect of miss-
ing data on the primary meta-analyses. Ongoing projects
will be classified as studies awaiting classification.
Unit of analysis issues
In case of investigators report on cluster-randomized
trial data as if randomization was performed at individ-
ual level rather than the cluster, a request to study au-
thors for the intra-cluster correlation coefficient (ICC)
will be submitted. In case of failing to obtain the infor-
mation, the study will seek external ICC estimates from
similar studies or available resources [38]. The study will
use the established ICC to reanalyze the trial data to ob-
tain approximate correct analyses according to descrip-
tion in the Cochrane Handbook for Systematic Reviews
of Interventions [34]. A sensitivity analyses to assess the
potential bias that may have occurred as a result of the
inadequately controlled clustered trials will be per-
formed. Further, the study will perform sensitivity ana-
lyses if the ICCs were obtained from external sources
to assess the potential biasing effects of inadequately
controlled cluster-randomized trials [39].
Assessment of heterogeneity
For the review of the intervention effects, heterogeneity
will be assessed by inspecting a forest plot initially and
later through the Cochran’s chi-square test using a 10 %
level of significance cut-off, and I2 statistic where values
of 25, 50, and 75 % reflect low, medium, and high het-
erogeneity, respectively [34, 37]. For the review of bar-
riers and facilitators, we will record differences across
the studies with regard to settings, participants, barriers,
and facilitators to the uptake of self-testing, for example,
and these will inform the analyses.
Sensitivity analysis
In case the identified studies are similar enough that it
would be sensible to combine them in a meta-analysis,
we will conduct sensitivity analyses to investigate the ro-
bustness of the results to risk of bias (i.e., omitting any
studies with high risk of bias) and method of meta-
analysis (i.e., random effects vs. fixed effect). We will
conduct sensitivity analysis to (i) evaluate the effect of
excluding studies unable to meet each quality criterion
affect the overall estimate and (ii) evaluate the change in
the results if only high-quality studies where included.
Assessment of reporting biases
The study will employ strategies to search for and in-
clude relevant unpublished studies in order to reduce
publication bias. These strategies will include searching
the gray literature, including conference proceedings
(e.g., 1st International symposium on self-testing for
HIV and International AIDS Society) and prospective
trial registration database to overcome time-lag bias. A
funnel plot will be used to investigate the risk of publica-
tion bias by intervention type, provided 10 or more stud-
ies are included in the analysis for each intervention
type. The funnel plot will be critically examined for
asymmetry by both visually and use of formal tests.
Grading the quality of evidence
The study will use the Grading of Recommendations
Assessment, Development and Evaluation (GRADE) ap-
proach to assess the quality of evidence related to each
of the primary and secondary outcomes for the review of
the intervention effects. The GRADE approach results in
an assessment of the quality of a body of evidence will
be categorized as high, moderate, low, and very low [40].
High-quality evidence refers to “further research is very
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unlikely to change our confidence in the estimate of
effect.” Moderate-quality evidence implies that “further
research is likely to have an important impact on our
confidence in the estimate of effect and may change the
estimate.” Low-quality evidence means “further research
is very likely to have an important impact on our confi-
dence in the estimate of effect and is likely to change the
effect.” Evidence is considered of very low quality if “we
have very little confidence in the effect estimate.” Two
authors (BN and DD) will independently assess the qual-
ity of evidence as implemented and described in the
GRADE profiler (GRADEpro) software [41].
For the review of barriers and facilitators, we will as-
sess the certainty of findings from qualitative studies
using the CerQual (certainty of qualitative evidence) ap-
proach. Certainty refers to how likely it is that the review
finding happens in a context of the included studies and
could happen elsewhere. In this approach, assessment of
certainty is based on two factors: the methodological
quality of individual studies and the plausibility of each
study finding. We will use an adaptation of the CASP
tool for qualitative studies to assess the methodological
quality of individual studies [36]. We will also assess the
plausibility of each study finding by looking at the extent
to which we are able to identify a clear pattern across
the individual study data. This pattern could include, for
example circumstances where findings are consistent
across multiple contexts or where the review finding in-
corporates explanations for any variability across individ-
ual studies. As a final step, we will prepare summary of
findings of the qualitative evidence synthesis. The sum-
mary tables will provide key findings, the certainty of
evidence for each finding, and explanation of the as-
sessment of the certainty of the qualitative evidence
[36]. We will use three levels to indicate the certainty
of the qualitative evidence—high, moderate, and low.
High certainty will refer to findings drawn from gener-
ally well-conducted studies with high levels of plausibil-
ity. Moderate certainty will refer to findings drawn
from studies with concerns related to either plausibility
or methodological quality. Low certainty will refer to
findings drawn from studies with concerns regarding
both the methodological quality and plausibility of the
finding.
Qualitative data analysis and synthesis
For the review of barriers and facilitators, we will con-
duct the qualitative synthesis for types of facilitators
and barriers related to uptake of testing. The aim of the
synthesis is to enhance understanding of questions re-
garding “what works for whom and in what context”
and to identify “barriers” and “facilitators” to the uptake
of self-testing. The qualitative data analysis will base on
thematic synthesis of qualitative research. Two authors
will independently code key descriptive themes on
types of facilitators and barriers, related with uptake of
self-testing. We will discuss the resulting themes and
sub-themes within the study team to examine their
relationship to the review outcomes. The qualitative
synthesis will then proceed by using the “descriptive
themes” to develop “analytical themes,” which will be
interpreted in reference to the review aims.
Discussion
Achieving universal coverage of HIV testing for the gen-
eral populations in Africa with scarce resources requires
the implementation of innovative and cost-effective
community-based HIV testing strategies, such as self-
testing. The findings from this systematic review will
inform on the knowledge gaps on the use of HIVST,
yield and linkage to ARV treatment, incidence of social
harms, and facilitators or barriers to uptake of HIVST
among adults in Africa. We anticipate that our findings
will guide the development of HIV self-testing policy,
which is virtually non-existent at present in most
African countries.
Presenting and reporting of results
This protocol will follow the Preferred Reporting Items
for Systematic Review and Meta-Analysis Protocols
(Additional file 4) 2015 Statement [42]. We will present
the results of this review according to the Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines. A PRISMA flow chart
will be produced to ensure transparency of the process
[43]. A table of all included studies will be included in
the final review, and the reasons for exclusion of studies
will be clearly documented. Where statistical pooling is
not possible, we will present the findings in narrative
form using tables and figures to aid in data presentation.
Interpretation of findings
The results of the review will be discussed in the context
of the quality of evidence, the limitations of the review,
and the strengths of the findings, with emphasis on their
implications for the current HIV self-testing practice and
the potential for future research.
Additional files
Additional file 1: Appendix 1: Describing details of search strategy.
(PDF 74 kb)
Additional file 2: Appendix 2: Systematic review data extraction form:
Observational quantitative and qualitative studies. (PDF 159 kb)
Additional file 3: DATA EXTRACTION FORM. (DOCX 115 kb)
Additional file 4: PRISMA-P (Preferred Reporting Items for Systematic
review and Meta-Analysis Protocols) 2015 checklist: recommended items
to address in a systematic review protocol. (DOC 81 kb)
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